NHS National Framework for Supply of Generics Housekeeping and Oral Products

About

NHS England awarded a contract to Drugsrus Ltd, Panpharma UK Limited, Accord-UK Ltd, Fresenius Kabi Limited, Kent Pharma Ltd, Wockhardt UK Limited, Luye Pharma Ltd, Bowmed Ibisqus Limited, Aspire Pharma Limited, Morningside Pharmaceuticals, and Milp for the supply of generics housekeeping products and oral products under the NHS National Framework.

The framework commenced on 1 June 2025, with call-off periods varying by region and product category: Orals (plus non-parenteral) products for Midlands and Southwest, Northwest and London North, and London South and Northeast each run for 24 months until 31 May 2027; Hospital Only products for Midlands and Southwest and London South and Northeast run for 12 months until 31 May 2026, while Northwest and London North run for 20 months until 31 January 2027.

The framework includes an option to extend for up to a total of 48 months at the discretion of the Authority.

The contract value is £11,656,086.